Pityriasis rosea as a leading manifestation of COVID‐19 infection

Reine Merhy, Anne-Sophie Sarkis, F Stéphan

2020Journal of the European Academy of Dermatology and Venereology21 citationsDOI Open Access PDF

Abstract

as well as a novel anti-androgen (proxalutamide) in the treatment of COVID-19 (NCT04446429).

Topics & Concepts

MedicineSAINTPityriasis roseaCoronavirus disease 2019 (COVID-19)University hospitalFamily medicineTraditional medicineDermatologyHistoryArt historyInternal medicineDiseaseInfectious disease (medical specialty)Dermatological and COVID-19 studiesParvovirus B19 Infection StudiesSkin Diseases and Diabetes